HealthcareServices

Menopause Digital Hormone Balancing App Market Forecast 2026–2035: How to Leverage Market Growth

March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the menopause digital hormone balancing app market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Menopause Digital Hormone Balancing App Market size between 2026 and 2035?

The menopause digital hormone balancing app market size has experienced swift expansion over recent years. It is projected to increase from $1.52 billion in 2025 to $1.79 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.3%. This historic growth is primarily due to several factors, including growing awareness of menopause health management, increasing smartphone penetration among women, rising adoption of digital health solutions, the expansion of wellness-focused mobile apps, and an increased focus on preventive healthcare.

The menopause digital hormone balancing app market is projected for significant expansion over the coming years. Its valuation is set to reach $3.35 billion by 2030, driven by a compound annual growth rate (CAGR) of 17.0%. This projected growth is fueled by several factors, including a heightened demand for tailored digital therapeutics, greater integration with wearable health devices, the proliferation of subscription-based health applications, an expanding emphasis on comprehensive menopause care, and the rising adoption of AI-powered health insights. Key trends anticipated during this period encompass the wider embrace of personalized menopause management apps, expanded utilization of symptom tracking and analytical tools, increasing integration of hormone monitoring capabilities, the broadening of virtual health coaching offerings, and a sharpened emphasis on user-focused app design.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28265&type=smp

Which Drivers Are Impacting Market Performance In The Menopause Digital Hormone Balancing App Market?

The rising adoption of smartphones is expected to propel the growth of the menopause digital hormone balancing app market going forward. Smartphone penetration refers to the percentage of a population or target market that owns or actively uses a smartphone. The increase in smartphone penetration is driven by the greater affordability of smartphones, making them accessible to a larger population. Higher smartphone penetration aids menopause digital hormone balancing apps by expanding their potential user base, enabling more women to conveniently access symptom tracking, hormone monitoring, lifestyle guidance, and educational resources on their devices. For instance, in February 2023, according to the GSM Association (GSMA), a UK-based industry organization representing mobile network operators and companies, smartphone penetration in sub-Saharan Africa is projected to significantly rise, reaching 87% by 2030, up from 51% in 2022. Therefore, the increasing smartphone penetration is a key driver for the growth of the menopause digital hormone balancing app market.

What Segment Types Are Examined In The Menopause Digital Hormone Balancing App Market?

The menopause digital hormone balancing app market covered in this report is segmented –

1) By App Type: Symptom Tracking, Hormone Monitoring, Lifestyle Management, Educational Apps, Other App Types

2) By Platform: iPhone Operating System, Android, Web-Based

3) By Subscription Model: Free, Paid, Freemium

4) By End-User: Women, Healthcare Providers, Clinics, Other End-Users

Subsegments:

1) By Symptom Tracking: Hot Flashes, Mood Swings, Sleep Disturbances

2) By Hormone Monitoring: Estrogen Levels, Progesterone Levels, Testosterone Levels

3) By Lifestyle Management: Nutrition Guidance, Exercise Regimens, Stress Management

4) By Educational Apps: Menopause Education, Hormone Therapy Information, Bone Health

5) By Other App Types: Community Support Platforms, Virtual Consultations, Medication Reminders

What Trends Are Projected To Support The Growth Of The Menopause Digital Hormone Balancing App Market?

Companies operating in the menopause digital hormone balancing app market are prioritizing the creation of advanced solutions, such as a clinical decision-support engine. This technology facilitates the structured collection of patient data and its real-time evaluation against evidence-based menopause pathways, enabling the provision of personalized management recommendations at the point of care. A clinical decision-support engine is defined as a software system designed to assist healthcare professionals in making informed and evidence-based decisions about patient care, offering structured guidance and recommendations based on patient-specific data. For example, in July 2025, University College London Hospitals (UCLH), a UK-based healthcare provider specializing in women’s health and menopause care, partnered with University College London (UCL) to launch the MENO.pause app. This digital clinical decision-support platform is developed to aid clinicians in managing patients’ menopause symptoms. The app integrates evidence-based clinical guidelines from the National Institute for Health and Care Excellence (NICE), the British Menopause Society (BMS), and the British Gynaecological Cancer Society (BGCS), providing personalized treatment recommendations based on patient history and risk factors. Moreover, the platform assists in risk stratification for high-risk patients, optimizes hormone replacement therapy (HRT) decisions, and simplifies referral pathways for complex or specialist cases through an intuitive, workflow-integrated interface suitable for use in primary and secondary care.

Who Are The Prominent Global Companies Shaping The Menopause Digital Hormone Balancing App Market Landscape?

Major companies operating in the menopause digital hormone balancing app market are Chorus Health Inc., Noom Inc., Maven Clinic Co., Forth Ltd., Join Olivia AB, Clue by BioWink GmbH, Balance App Ltd., Peppy Health Ltd., Elektra Health Inc., Eli Health Inc., FemTech Health Inc., Health and Her Ltd., Hormona Ltd., Lisa Health Inc., Mira Fertility Inc., Oova Life Inc., Stella LLC, Vira Health Ltd., Wild AI Ltd., Gennev Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/menopause-digital-hormone-balancing-app-global-market-report

How Does The Menopause Digital Hormone Balancing App Market Perform Across Major Global Regions?

North America was the largest region in the menopause digital hormone balancing app market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the menopause digital hormone balancing app market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Menopause Digital Hormone Balancing App Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28265&type=smp

Browse Through More Reports Similar to the Global Menopause Digital Hormone Balancing App Market 2026, By The Business Research Company

Hormone Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report

Womens Health App Market Report 2026

https://www.thebusinessresearchcompany.com/report/womens-health-app-global-market-report

Menopause Market Report 2026

https://www.thebusinessresearchcompany.com/report/menopause-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795